MX358496B - Yeast-based therapeutic for chronic hepatitis b infection. - Google Patents
Yeast-based therapeutic for chronic hepatitis b infection.Info
- Publication number
- MX358496B MX358496B MX2016003040A MX2016003040A MX358496B MX 358496 B MX358496 B MX 358496B MX 2016003040 A MX2016003040 A MX 2016003040A MX 2016003040 A MX2016003040 A MX 2016003040A MX 358496 B MX358496 B MX 358496B
- Authority
- MX
- Mexico
- Prior art keywords
- yeast
- infection
- chronic hepatitis
- hbv
- based therapeutic
- Prior art date
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Disclosed are yeast-based immunotherapeutic compositions, hepatitis B virus (HBV) antigens, and fusion proteins for the treatment and/or prevention of HBV infection and symptoms thereof, as well as methods of using the yeast-based immunotherapeutic compositions, HBV antigens, and fusion proteins for the prophylactic and/or therapeutic treatment of HBV and/or symptoms thereof.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161442204P | 2011-02-12 | 2011-02-12 | |
US201161496945P | 2011-06-14 | 2011-06-14 | |
PCT/US2012/024409 WO2012109404A1 (en) | 2011-02-12 | 2012-02-09 | Yeast-based therapeutic for chronic hepatitis b infection |
US201361507361P | 2013-07-13 | 2013-07-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX358496B true MX358496B (en) | 2018-08-23 |
Family
ID=51796058
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2013009310A MX337551B (en) | 2011-02-12 | 2012-02-09 | Yeast-based therapeutic for chronic hepatitis b infection. |
MX2016003040A MX358496B (en) | 2011-02-12 | 2012-02-09 | Yeast-based therapeutic for chronic hepatitis b infection. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2013009310A MX337551B (en) | 2011-02-12 | 2012-02-09 | Yeast-based therapeutic for chronic hepatitis b infection. |
Country Status (1)
Country | Link |
---|---|
MX (2) | MX337551B (en) |
-
2012
- 2012-02-09 MX MX2013009310A patent/MX337551B/en active IP Right Grant
- 2012-02-09 MX MX2016003040A patent/MX358496B/en unknown
Also Published As
Publication number | Publication date |
---|---|
MX337551B (en) | 2016-03-10 |
MX2013009310A (en) | 2014-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3266464A3 (en) | Yeast-based therapeutic for chronic hepatitis b infection | |
PH12018500572A1 (en) | Hepatitis b core protein modulators | |
MX2019003525A (en) | Hepatitis b core protein allosteric modulators. | |
WO2012047856A3 (en) | Novel inhibitors of secretion of hepatitis b virus antigens | |
MD20140035A2 (en) | Method for treating hepatitis C virus | |
PH12015501017A1 (en) | Alternative uses for hbv assembly effectors | |
WO2014160747A3 (en) | Compositions and methods for the treatment or prevention of human immunodeficiency virus infection | |
UA113956C2 (en) | PIRIMIDIN DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS | |
IN2014DN10288A (en) | ||
MX2013001237A (en) | Hepatitis c virus inhibitors. | |
EA201391515A1 (en) | INACTIVATED DENGE VIRUS VACCINE | |
HRP20190393T1 (en) | An antibody composition for prevention or treatment of mutant hepatitis b virus infection | |
WO2015031778A3 (en) | Compositions and methods for the treatment or prevention of tuberculosis | |
WO2012047267A3 (en) | Polyvalent immunogen | |
MX2011006516A (en) | Hepatitis c virus combination therapy. | |
WO2013033319A3 (en) | A cluster of neutralizing antibodies to hepatitis c virus | |
PH12017500820A1 (en) | Combination long acting compositions and methods for hepatitis c | |
PH12017500817A1 (en) | Long acting pharmaceutical compositions for hepatitis c | |
IN2015DN03925A (en) | ||
MX2014001158A (en) | Recombinant swine influenza virus and uses thereof. | |
MX2013009310A (en) | Yeast-based therapeutic for chronic hepatitis b infection. | |
WO2009008888A8 (en) | African swine virus polypeptides as vaccines and its therapeutic use thereof | |
WO2011109104A3 (en) | Molecular clone of hiv-1 |